Carocell Bio’s CEO Dr Mike Davies recently attended investment-focused BioSeed 2024 in London, UK, to present the company and meet investors and others from the life sciences community.
The meeting, which is organised annually by the Oxford-based OBN network, in its seventh year, is a fast-paced one-day pitching event. There, innovative early-stage life sciences companies seeking seed funding, present to and meet with an extensive audience of active life sciences investors.
Andy Round, Investment Director, Deepbridge Capital, who also attended BioSeed 2024, said: “It was a great day at BioSeed and Mike did a great job presenting what is a great investment opportunity!”
Mike will also be attending the Anglonordic Life Science Conference from 17-18 April in London.